Part,  Chapter, Paragraph

 1   II,     5.  1.  1|     affecting more than 22% of the incident patients.~Food Allergy~In
 2   II,     5.  3.  1|             Table 5.3.1. Estimated incident cases and deaths by selected
 3   II,     5.  3.  2|             survival (following up incident cases for a given time after
 4   II,     5.  3.  2|        indicators: down-staging of incident cases; reversal of initial
 5   II,     5.  5.  3|      Clarke, 1966 (*)~France~GP/MF~Incident cohort~149~16.1~9.3~Loiseau
 6   II,     5.  5.  3|            al., 1999~Iceland~GP/MF~Incident cohort~45~28.0~1.6~Olafsson
 7   II,     5.  5.  3|       Zielinski, 1974~Sweden~GP/MF~Incident cohort~39~15.7~2.5~Lindsten
 8   II,     5.  5.  3|                GP/MF~Prevalent and incident cohort~4001~1109.0~3.6~Nilsson
 9   II,     5.  5.  3|     Nilsson et al, 1997~U.K.~GP/MF~Incident cohort~149~58.3~2.6~Lhathoo
10   II,     5.  5.  3| heterogeneity in the definition of incident cases (symptom onset vs.
11   II,     5.  7.  3|       Five-year mortality rates in incident RRT patients are 52% in
12   II,     5.  7.  3|       five-year mortality rates in incident RRT patients per age group,
13   II,     5.  7.  4|     affecting more than 22% of the incident patients.~ ~Apart from international
14   II,     5.  7.  7|         kidney disease and risk of incident myocardial infarction and
15   II,     5.  8.  3|       Database was used to compare incident COPD patients (physician
16   II,     5.  8.  3|          total sum of diagnosis of incident COPD patients related to
17   II,     5.  8.  7|          COPD and risk factors for incident disease in a symptomatic
18   II,     5.  8.  7|       Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations
19   II,     5.  9.  3|           a generational increase (incident rate ratio = 2.63 and 95%
20   II,     7.  3.  4|       transport injury event is an incident involving a transport device
21  III,    10.  2.  1|        factors and their impact on incident non-fatal and fatal myocardial
22  III,    10.  4.  2|          promoters have no effect;~incident involving~clenbuterol: heart
23  III,    10.  4.  2|       During the follow-up of this incident, Swedish officials realised
24  III,    10.  5.  3|         Table 10.5.3.2. Number and incident rate of occupational diseases.~ ~
25  III,    10.  5.  3|         Table 10.5.3.4. Number and incident rate of non fatal occupational
26  III,    10.  5.  3|          well as construction with incident rates two-fold above average.
27  III,    10.  6.  3|      respondents recorded a sexual incident. Somewhat higher percentages
28   IV,    12. 10    |           on drug safety.~Critical incident reporting – voluntary online-reporting